JAMP PHARMA CORPORATION — Acyclovir Importer Profile
Pharmaceutical Importer · #13 buyer for Acyclovir · $954.4K import value · 37 shipments · CANADA · DGFT Verified
JAMP PHARMA CORPORATION is the #13 importer of Acyclovir from India with $954.4K in import value and 37 verified shipments. JAMP PHARMA CORPORATION holds a 1.0% market share in Acyclovir imports based in CANADA. The company sources from 1 verified supplier across 17 formulations shipped to 1 country. Overall, JAMP PHARMA CORPORATION imports 14 pharmaceutical products worth $13.3M across 9 therapeutic categories.
JAMP PHARMA CORPORATION — Acyclovir Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Acyclovir to JAMP PHARMA CORPORATION?
Verified from 37 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| V S INTERNATIONAL PRIVATE LIMITED | $954.4K | 37 | 100.0% |
JAMP PHARMA CORPORATION sources Acyclovir from 1 verified Indian supplier based on 37 customs records. The primary supplier is V S INTERNATIONAL PRIVATE LIMITED accounting for 100.0% of imports.
How Does JAMP PHARMA CORPORATION Compare to Nearest Acyclovir Importers?
Buyers ranked immediately above and below #13 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 8 | CAMBER PHARMACEUTICALS INC | UNITED STATES | $1.4M | 28 | $50.0K |
| 10 | EUGIA US LLC | UNITED STATES | $1.4M | 27 | $50.0K |
| 13 | JAMP PHARMA CORPORATION ★ | CANADA | $1.3M | 37 | $35.6K |
| 1 | MYLAN PHARMACEUTICALS INC, | UNITED STATES | $1.1M | 23 | $50.0K |
| 2 | MYLAN PHARMACEUTICALS INC | UNITED STATES | $1.1M | 21 | $50.0K |
JAMP PHARMA CORPORATION ranks #13 among 879 Acyclovir importers from India. Average shipment value of $35.6K compared to the market average of $21.4K. The closest competitors by value are CAMBER PHARMACEUTICALS INC and EUGIA US LLC.
Where Does JAMP PHARMA CORPORATION Import Acyclovir To?
Destination countries from 37 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| CANADA | $954.4K | 37 | 100.0% |
JAMP PHARMA CORPORATION imports Acyclovir to 1 country. The primary destination is CANADA receiving 100.0% of shipments worth $954.4K.
What Acyclovir Formulations Does JAMP PHARMA CORPORATION Import?
| Formulation | Value | Shipments |
|---|---|---|
| AG-VALACYCLOVIR 500 MG Valacyclovir Tabl | $185.0K | 6 |
| VALACYCLOVIR 500 MG VALACYCLOVIR TABLETS | $168.5K | 4 |
| AG-VALACYCLOVIR 500 MG VALACYCLOVIR TABLETS USP 500 MG | $106.0K | 9 |
| AG-VALACYCLOVIR 500 MG Valacyclovir Tablets USP 500 mg | $87.0K | 3 |
| VALACYCLOVIR 500 MG VALACYCLOVIR TABLETS USP 100 MG | $83.2K | 2 |
| AG-VALACYCLOVIR 500 MG VALACYCLOVIR TABLETS USP 100 MG | $82.5K | 2 |
| VALACYCLOVIR 500 MG VALACYCLOVIR TABLETSUSP 500 MG | $50.0K | 1 |
| VALACYCLOVIR 500 MG, VALACYCLOVIR TABLETS USP 500 MG | $50.0K | 1 |
| VALACYCLOVIR 500 MG - Valacyclovir Tablets USP 500 mg | $50.0K | 1 |
| AG-VALACYCLOVIR 500 MG - Valacyclovir Tablets USP 500 mg | $50.0K | 1 |
JAMP PHARMA CORPORATION imports 17 distinct Acyclovir formulations from India. The top formulation is AG-VALACYCLOVIR 500 MG Valacyclovir Tabl with 6 shipments worth $185.0K.
Regulatory Requirements: Importing Acyclovir into Canada
What JAMP PHARMA CORPORATION and other importers must comply with to import Acyclovir from India
Regulatory Authority
Health Canada (HC)
Approval Process for Generic Acyclovir
Abbreviated New Drug Submission (ANDS) referencing an approved Canadian Reference Product. Comparative bioavailability study required.
Typical timeline: 12–18 months
GMP Requirements
Health Canada GMP (GUI-0001); on-site Drug Establishment Licence (DEL) inspection
Import Licence & Documentation
Drug Establishment Licence (DEL) for importer; Drug Identification Number (DIN) required
Labeling & Packaging
Bilingual (English/French) labeling required; Canadian format per Health Canada guidance
Note: Subject to C.01.014.6 annual review and Good Import Practices requirements.
Regulatory information is provided for general reference based on publicly available HC guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with HC or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Acyclovir from India and How Much Does JAMP PHARMA CORPORATION Import?
India exported $18.8M worth of Acyclovir through 5,956 shipments from 358 suppliers to 152 countries, serving 879 buyers globally. JAMP PHARMA CORPORATION imports $954.4K of this total, accounting for 1.0% of India's Acyclovir exports with 37 shipments from CANADA. This is verified from 37 customs shipment records covering 17 distinct formulations.
What Is the Average Order Value for JAMP PHARMA CORPORATION's Acyclovir Imports?
JAMP PHARMA CORPORATION's average Acyclovir order value is $25.8K per consignment, based on 37 shipments totaling $954.4K. JAMP PHARMA CORPORATION is based in CANADA and ranks #13 among all Acyclovir importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Acyclovir to JAMP PHARMA CORPORATION?
JAMP PHARMA CORPORATION sources Acyclovir from 1 verified Indian supplier: V S INTERNATIONAL PRIVATE LIMITED ($954.4K, 100.0%). This is based on 37 customs records.
How Does JAMP PHARMA CORPORATION Compare to Other Acyclovir Importers?
JAMP PHARMA CORPORATION ranks #13 among 879 Acyclovir importers from India with a 1.0% market share. The top 3 importers are EVERSANA LIFE SCIENCE SERVICES ($4.6M), XXMBEXXPHAXXACEXXICAXX IXX ($3.2M), SIVEM PHARMACEUTICALS ($1.6M). JAMP PHARMA CORPORATION processed 37 shipments from CANADA.
What Other Antivirals Products Does JAMP PHARMA CORPORATION Import?
JAMP PHARMA CORPORATION also imports these antivirals products. Each links to the detailed product page.
About JAMP PHARMA CORPORATION
JAMP PHARMA CORPORATION imports 14 products worth $13.3M. Beyond Acyclovir, top products include Dapagliflozin, Apixaban, Valacyclovir, Bisoprolol, Natural. View the complete JAMP PHARMA CORPORATION profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Acyclovir — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Acyclovir shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: JAMP PHARMA CORPORATION matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as JAMP PHARMA CORPORATION's capped import value divided by total capped export value for Acyclovir across all Indian exporters.
- 5.Verified Records: This page is backed by 37 individual customs records matching JAMP PHARMA CORPORATION importing Acyclovir, covering 17 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 152+ countries, 879+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Acyclovir Import Data for JAMP PHARMA CORPORATION
Access order-level details, pricing data, supplier connections, and competitive analysis for JAMP PHARMA CORPORATION's Acyclovir imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
JAMP PHARMA CORPORATION
Full Company Profile →
14 products · $13.3M total trade · 9 categories
JAMP PHARMA CORPORATION × Acyclovir
Verified from customs records
Company Overview
Top Products by JAMP PHARMA CORPORATION
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for JAMP PHARMA CORPORATION.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Acyclovir. For current order-level data, contact TransData Nexus.